Stock listing

NEO Stock Price, News, Filings & Events — Neogenomics, Inc.

Selected listing: NEO · NASDAQ · USD · US

This page tracks Neogenomics, Inc.'s NEO:NASDAQ listing on NASDAQ in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following NEO:NASDAQ. NEO:NASDAQ is the stock-level entry point for investors researching Neogenomics, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Neogenomics, Inc. is a publicly traded company listed under the ticker NEO, operating in the American market. The company has a market capitalization of approximately $1.81 billion. Neogenomics specializes in cancer genetics and provides a range of diagnostic services to healthcare providers.

NEO:NASDAQUSDUSUpdated July 31, 2026
Neogenomics, Inc. logo
Ticker
NEO:NASDAQ
Asset type
Stock
Market cap
$1.96B
Sector
Health Services
Industry
Medical/Nursing Services
Exchange
NASDAQ
Currency
USD

Neogenomics, Inc. NEO:NASDAQ stock context

This page tracks Neogenomics, Inc.'s NEO:NASDAQ listing on NASDAQ in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following NEO:NASDAQ. NEO:NASDAQ is the stock-level entry point for investors researching Neogenomics, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Neogenomics, Inc. is a publicly traded company listed under the ticker NEO, operating in the American market. The company has a market capitalization of approximately $1.81 billion. Neogenomics specializes in cancer genetics and provides a range of diagnostic services to healthcare providers.

Latest news from Neogenomics, Inc.

All Neogenomics, Inc. news →

Neogenomics, Inc. earnings calls

Research Neogenomics, Inc.

Alternate listings